Wells Fargo’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-49,373
| Closed | -$150K | – | 6704 |
|
|
2024
Q4 | $150K | Buy |
49,373
+10,675
| +28% | +$32.5K | ﹤0.01% | 4478 |
|
|
2024
Q3 | $201K | Sell |
38,698
-24,232
| -39% | -$126K | ﹤0.01% | 4192 |
|
|
2024
Q2 | $162K | Buy |
62,930
+7,857
| +14% | +$20.2K | ﹤0.01% | 4291 |
|
|
2024
Q1 | $271K | Buy |
55,073
+16,794
| +44% | +$82.6K | ﹤0.01% | 3920 |
|
|
2023
Q4 | $336K | Buy |
38,279
+2,946
| +8% | +$25.9K | ﹤0.01% | 3770 |
|
|
2023
Q3 | $405K | Sell |
35,333
-36,674
| -51% | -$421K | ﹤0.01% | 3633 |
|
|
2023
Q2 | $1.82M | Buy |
72,007
+17,990
| +33% | +$455K | ﹤0.01% | 2836 |
|
|
2023
Q1 | $1.74M | Sell |
54,017
-30,220
| -36% | -$973K | ﹤0.01% | 2802 |
|
|
2022
Q4 | $1.56M | Sell |
84,237
-8,268
| -9% | -$153K | ﹤0.01% | 2796 |
|
|
2022
Q3 | $2.5M | Buy |
92,505
+168
| +0.2% | +$4.54K | ﹤0.01% | 2414 |
|
|
2022
Q2 | $1.28M | Sell |
92,337
-11,093
| -11% | -$153K | ﹤0.01% | 2948 |
|
|
2022
Q1 | $2.02M | Sell |
103,430
-66,809
| -39% | -$1.3M | ﹤0.01% | 3104 |
|
|
2021
Q4 | $2.78M | Sell |
170,239
-323,145
| -65% | -$5.28M | ﹤0.01% | 2979 |
|
|
2021
Q3 | $13.7M | Buy |
493,384
+86,375
| +21% | +$2.41M | ﹤0.01% | 1890 |
|
|
2021
Q2 | $12.1M | Sell |
407,009
-13,373
| -3% | -$396K | ﹤0.01% | 2015 |
|
|
2021
Q1 | $11.8M | Sell |
420,382
-9,418
| -2% | -$263K | ﹤0.01% | 1995 |
|
|
2020
Q4 | $12.2M | Buy |
429,800
+177,807
| +71% | +$5.04M | ﹤0.01% | 1923 |
|
|
2020
Q3 | $6.34M | Buy |
251,993
+174,266
| +224% | +$4.38M | ﹤0.01% | 2265 |
|
|
2020
Q2 | $1.9M | Buy |
77,727
+21,151
| +37% | +$516K | ﹤0.01% | 3248 |
|
|
2020
Q1 | $837K | Buy |
56,576
+11,674
| +26% | +$173K | ﹤0.01% | 3557 |
|
|
2019
Q4 | $728K | Buy |
44,902
+16,503
| +58% | +$268K | ﹤0.01% | 4003 |
|
|
2019
Q3 | $369K | Buy |
28,399
+1,718
| +6% | +$22.3K | ﹤0.01% | 4449 |
|
|
2019
Q2 | $346K | Buy |
26,681
+6,848
| +35% | +$88.8K | ﹤0.01% | 4494 |
|
|
2019
Q1 | $313K | Buy |
19,833
+1,654
| +9% | +$26.1K | ﹤0.01% | 4535 |
|
|
2018
Q4 | $366K | Buy |
18,179
+2,479
| +16% | +$49.9K | ﹤0.01% | 4388 |
|
|
2018
Q3 | $390K | Buy |
15,700
+1,218
| +8% | +$30.3K | ﹤0.01% | 4482 |
|
|
2018
Q2 | $398K | Sell |
14,482
-11,153
| -44% | -$307K | ﹤0.01% | 4505 |
|
|
2018
Q1 | $789K | Buy |
25,635
+11,695
| +84% | +$360K | ﹤0.01% | 4010 |
|
|
2017
Q4 | $499K | Sell |
13,940
-5,017
| -26% | -$180K | ﹤0.01% | 4295 |
|
|
2017
Q3 | $522K | Sell |
18,957
-4,327
| -19% | -$119K | ﹤0.01% | 4193 |
|
|
2017
Q2 | $615K | Sell |
23,284
-47,864
| -67% | -$1.26M | ﹤0.01% | 3992 |
|
|
2017
Q1 | $1.48M | Sell |
71,148
-14,632
| -17% | -$304K | ﹤0.01% | 3405 |
|
|
2016
Q4 | $1.78M | Buy |
85,780
+74,793
| +681% | +$1.55M | ﹤0.01% | 3206 |
|
|
2016
Q3 | $178K | Buy |
10,987
+1,759
| +19% | +$28.5K | ﹤0.01% | 4375 |
|
|
2016
Q2 | $126K | Sell |
9,228
-1,291
| -12% | -$17.6K | ﹤0.01% | 4518 |
|
|
2016
Q1 | $184K | Buy |
10,519
+3,126
| +42% | +$54.7K | ﹤0.01% | 4310 |
|
|
2015
Q4 | $253K | Sell |
7,393
-1,367
| -16% | -$46.8K | ﹤0.01% | 4173 |
|
|
2015
Q3 | $261K | Buy |
8,760
+1,442
| +20% | +$43K | ﹤0.01% | 4183 |
|
|
2015
Q2 | $234K | Buy |
7,318
+2,620
| +56% | +$83.8K | ﹤0.01% | 4392 |
|
|
2015
Q1 | $97K | Buy |
4,698
+2,851
| +154% | +$58.9K | ﹤0.01% | 4590 |
|
|
2014
Q4 | $32K | Buy |
1,847
+33
| +2% | +$572 | ﹤0.01% | 4982 |
|
|
2014
Q3 | $36K | Buy |
1,814
+676
| +59% | +$13.4K | ﹤0.01% | 4916 |
|
|
2014
Q2 | $39K | Buy |
+1,138
| New | +$39K | ﹤0.01% | 4937 |
|